Graham Cooper Named CFO of Receptos

Receptos, a San Diego-based biopharmaceutical company working to develop treatments for immune and metabolic diseases, has a new CFO: Graham Cooper. Cooper was previously CFO at Geron Corporation and Orexigen Therapeutics.

Receptos Raises $25 Million

Receptos Inc., a San Diego-based developer of GPCR therapeutics, has raised $25 million in tranched-out Series A funding. Backers include ARCH Venture Partners, Flagship Ventures, Lilly Ventures and Venrock.

PEHUB Community

Join the 12504 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget